Vanguard Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,519,968
| Closed | -$1.26B | – | 4364 |
|
|
2025
Q1 | $1.26B | Sell |
9,519,968
-201,392
| -2% | -$25.1M | 0.02% | 576 |
|
|
2024
Q4 | $812M | Buy |
9,721,360
+93,107
| +1% | +$7.65M | 0.01% | 781 |
|
|
2024
Q3 | $704M | Buy |
9,628,253
+21,347
| +0.2% | +$1.6M | 0.01% | 837 |
|
|
2024
Q2 | $658M | Buy |
9,606,906
+380,925
| +4% | +$26.4M | 0.01% | 824 |
|
|
2024
Q1 | $638M | Buy |
9,225,981
+131,679
| +1% | +$9.05M | 0.01% | 869 |
|
|
2023
Q4 | $651M | Buy |
9,094,302
+554,577
| +6% | +$31.9M | 0.01% | 828 |
|
|
2023
Q3 | $445M | Buy |
8,539,725
+43,689
| +0.5% | +$2.55M | 0.01% | 953 |
|
|
2023
Q2 | $538M | Buy |
8,496,036
+52,879
| +0.6% | +$3.3M | 0.01% | 882 |
|
|
2023
Q1 | $457M | Buy |
8,443,157
+123,908
| +1% | +$5.99M | 0.01% | 957 |
|
|
2022
Q4 | $440M | Buy |
8,319,249
+203,229
| +3% | +$10.2M | 0.01% | 955 |
|
|
2022
Q3 | $378M | Buy |
8,116,020
+35,822
| +0.4% | +$1.87M | 0.01% | 1000 |
|
|
2022
Q2 | $461M | Buy |
8,080,198
+291,729
| +4% | +$16.5M | 0.01% | 909 |
|
|
2022
Q1 | $477M | Buy |
7,788,469
+912,268
| +13% | +$47.4M | 0.01% | 1001 |
|
|
2021
Q4 | $360M | Sell |
6,876,201
-15,368
| -0.2% | -$646K | 0.01% | 1213 |
|
|
2021
Q3 | $257M | Buy |
6,891,569
+63,132
| +0.9% | +$2.19M | 0.01% | 1441 |
|
|
2021
Q2 | $279M | Buy |
6,828,437
+106,744
| +2% | +$3.95M | 0.01% | 1415 |
|
|
2021
Q1 | $228M | Buy |
6,721,693
+240,349
| +4% | +$8.34M | 0.01% | 1518 |
|
|
2020
Q4 | $206M | Buy |
6,481,344
+252,046
| +4% | +$6.62M | 0.01% | 1449 |
|
|
2020
Q3 | $160M | Buy |
6,229,298
+958,854
| +18% | +$21.9M | 0.01% | 1412 |
|
|
2020
Q2 | $135M | Buy |
5,270,444
+10,614
| +0.2% | +$215K | ﹤0.01% | 1512 |
|
|
2020
Q1 | $80.8M | Buy |
5,259,830
+1,040,240
| +25% | +$22.6M | ﹤0.01% | 1647 |
|
|
2019
Q4 | $145M | Buy |
4,219,590
+37,460
| +0.9% | +$450K | ﹤0.01% | 1567 |
|
|
2019
Q3 | $31.2M | Sell |
4,182,130
-8,051
| -0.2% | -$77.2K | ﹤0.01% | 2278 |
|
|
2019
Q2 | $54.4M | Sell |
4,190,181
-26,354
| -0.6% | -$338K | ﹤0.01% | 2059 |
|
|
2019
Q1 | $51.4M | Buy |
4,216,535
+282,605
| +7% | +$3.61M | ﹤0.01% | 2072 |
|
|
2018
Q4 | $44.8M | Sell |
3,933,930
-9,862
| -0.3% | -$159K | ﹤0.01% | 2081 |
|
|
2018
Q3 | $85.6M | Buy |
3,943,792
+69,950
| +2% | +$1.46M | ﹤0.01% | 1880 |
|
|
2018
Q2 | $68.5M | Buy |
3,873,842
+135,165
| +4% | +$2.74M | ﹤0.01% | 1963 |
|
|
2018
Q1 | $78.7M | Buy |
3,738,677
+8,419
| +0.2% | +$164K | ﹤0.01% | 1844 |
|
|
2017
Q4 | $54M | Buy |
3,730,258
+264,005
| +8% | +$4.08M | ﹤0.01% | 2024 |
|
|
2017
Q3 | $54.7M | Buy |
3,466,253
+744,521
| +27% | +$10.9M | ﹤0.01% | 1993 |
|
|
2017
Q2 | $33.8M | Sell |
2,721,732
-20,155
| -0.7% | -$234K | ﹤0.01% | 2217 |
|
|
2017
Q1 | $44.6M | Buy |
2,741,887
+186,165
| +7% | +$2.69M | ﹤0.01% | 2064 |
|
|
2016
Q4 | $38.6M | Buy |
2,555,722
+96,351
| +4% | +$1.36M | ﹤0.01% | 2102 |
|
|
2016
Q3 | $37.5M | Buy |
2,459,371
+103,658
| +4% | +$4.19M | ﹤0.01% | 2068 |
|
|
2016
Q2 | $91.4M | Buy |
2,355,713
+781,550
| +50% | +$28.1M | 0.01% | 1576 |
|
|
2016
Q1 | $43.8M | Buy |
1,574,163
+174,451
| +12% | +$5.81M | ﹤0.01% | 1925 |
|
|
2015
Q4 | $75.3M | Buy |
1,399,712
+438,581
| +46% | +$22.1M | 0.01% | 1664 |
|
|
2015
Q3 | $38.5M | Buy |
961,131
+237,138
| +33% | +$7.73M | ﹤0.01% | 1994 |
|
|
2015
Q2 | $23.1M | Buy |
723,993
+94,118
| +15% | +$2.39M | ﹤0.01% | 2290 |
|
|
2015
Q1 | $15M | Buy |
629,875
+180,872
| +40% | +$4.05M | ﹤0.01% | 2451 |
|
|
2014
Q4 | $7.92M | Buy |
449,003
+44,095
| +11% | +$689K | ﹤0.01% | 2649 |
|
|
2014
Q3 | $5.55M | Buy |
404,908
+9,976
| +3% | +$150K | ﹤0.01% | 2767 |
|
|
2014
Q2 | $6.66M | Buy |
394,932
+57,292
| +17% | +$947K | ﹤0.01% | 2700 |
|
|
2014
Q1 | $6.14M | Buy |
+337,640
| New | +$6.1M | ﹤0.01% | 2727 |
|
Other funds holding ITCI
KIM
HNB